81 related articles for article (PubMed ID: 16139873)
1. GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism.
Lockyer S; Okuyama K; Begum S; Le S; Sun B; Watanabe T; Matsumoto Y; Yoshitake M; Kambayashi J; Tandon NN
Thromb Res; 2006; 118(3):371-80. PubMed ID: 16139873
[TBL] [Abstract][Full Text] [Related]
2. An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families.
Matus V; Valenzuela G; Sáez CG; Hidalgo P; Lagos M; Aranda E; Panes O; Pereira J; Pillois X; Nurden AT; Mezzano D
J Thromb Haemost; 2013 Sep; 11(9):1751-9. PubMed ID: 23815599
[TBL] [Abstract][Full Text] [Related]
3. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
Hermans C; Wittevrongel C; Thys C; Smethurst PA; Van Geet C; Freson K
J Thromb Haemost; 2009 Aug; 7(8):1356-63. PubMed ID: 19552682
[TBL] [Abstract][Full Text] [Related]
4. Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis.
Ye Y; Yang L; Leng M; Wang Q; Wu J; Wan W; Wang H; Li L; Peng Y; Chai S; Meng Z
Front Pharmacol; 2023; 14():1255069. PubMed ID: 38026984
[No Abstract] [Full Text] [Related]
5. Platelets modulate cardiac remodeling via the collagen receptor GPVI after acute myocardial infarction.
Reusswig F; Dille M; Krüger E; Ortscheid J; Feige T; Gorressen S; Fischer JW; Elvers M
Front Immunol; 2023; 14():1275788. PubMed ID: 38274818
[TBL] [Abstract][Full Text] [Related]
6. Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models.
Jain S; Russell S; Ware J
J Thromb Haemost; 2009 Oct; 7(10):1713-7. PubMed ID: 19624454
[TBL] [Abstract][Full Text] [Related]
7. Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion.
Leatherdale A; Parker D; Tasneem S; Wang Y; Bihan D; Bonna A; Hamaia SW; Gross PL; Ni H; Doble BW; Lillicrap D; Farndale RW; Hayward CPM
J Thromb Haemost; 2021 Feb; 19(2):547-561. PubMed ID: 33179420
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence of a native GPVI dimer at the platelet surface.
Herr AB
J Thromb Haemost; 2009 Aug; 7(8):1344-6. PubMed ID: 19496922
[No Abstract] [Full Text] [Related]
9. Glycoprotein VI in securing vascular integrity in inflamed vessels.
Boulaftali Y; Mawhin MA; Jandrot-Perrus M; Ho-Tin-Noé B
Res Pract Thromb Haemost; 2018 Apr; 2(2):228-239. PubMed ID: 30046725
[TBL] [Abstract][Full Text] [Related]
10. The future of glycoprotein VI as an antithrombotic target.
Zahid M; Mangin P; Loyau S; Hechler B; Billiald P; Gachet C; Jandrot-Perrus M
J Thromb Haemost; 2012 Dec; 10(12):2418-27. PubMed ID: 23020554
[TBL] [Abstract][Full Text] [Related]
11. A tail of two ITAMs: GPVI/FcRγ and FcγRIIa's role in platelet activation and thrombus stability.
Neeves KB
Res Pract Thromb Haemost; 2021 Jul; 5(5):e12564. PubMed ID: 34263108
[No Abstract] [Full Text] [Related]
12. Platelet adhesion to collagen.
Nuyttens BP; Thijs T; Deckmyn H; Broos K
Thromb Res; 2011 Jan; 127 Suppl 2():S26-9. PubMed ID: 21193111
[TBL] [Abstract][Full Text] [Related]
13. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice.
Bender M; May F; Lorenz V; Thielmann I; Hagedorn I; Finney BA; Vögtle T; Remer K; Braun A; Bösl M; Watson SP; Nieswandt B
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):926-34. PubMed ID: 23448972
[TBL] [Abstract][Full Text] [Related]
14. A humanized glycoprotein VI (GPVI) mouse model to assess the antithrombotic efficacies of anti-GPVI agents.
Mangin PH; Tang C; Bourdon C; Loyau S; Freund M; Hechler B; Gachet C; Jandrot-Perrus M
J Pharmacol Exp Ther; 2012 Apr; 341(1):156-63. PubMed ID: 22238212
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin.
Ahmed MU; Kaneva V; Loyau S; Nechipurenko D; Receveur N; Le Bris M; Janus-Bell E; Didelot M; Rauch A; Susen S; Chakfé N; Lanza F; Gardiner EE; Andrews RK; Panteleev M; Gachet C; Jandrot-Perrus M; Mangin PH
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2127-2142. PubMed ID: 32698684
[TBL] [Abstract][Full Text] [Related]
16. The localization, origin, and impact of platelets in the tumor microenvironment are tumor type-dependent.
Le Chapelain O; Jadoui S; Gros A; Barbaria S; Benmeziane K; Ollivier V; Dupont S; Solo Nomenjanahary M; Mavouna S; Rogozarski J; Mawhin MA; Caligiuri G; Delbosc S; Porteu F; Nieswandt B; Mangin PH; Boulaftali Y; Ho-Tin-Noé B
J Exp Clin Cancer Res; 2024 Mar; 43(1):84. PubMed ID: 38493157
[TBL] [Abstract][Full Text] [Related]
17. Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?
Agbani EO; Hers I; Poole AW
Blood Adv; 2023 Apr; 7(8):1615-1619. PubMed ID: 36574232
[No Abstract] [Full Text] [Related]
18. Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment.
Barriuso I; Worner F; Vilahur G
J Cardiovasc Dev Dis; 2022 Nov; 9(11):. PubMed ID: 36421932
[TBL] [Abstract][Full Text] [Related]
19. Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases.
Heestermans M; Poenou G; Duchez AC; Hamzeh-Cognasse H; Bertoletti L; Cognasse F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361963
[TBL] [Abstract][Full Text] [Related]
20. Endogenous SOD2 (Superoxide Dismutase) Regulates Platelet-Dependent Thrombin Generation and Thrombosis During Aging.
Sonkar VK; Eustes AS; Ahmed A; Jensen M; Solanki MV; Swamy J; Kumar R; Fidler TP; Houtman JCD; Allen BG; Spitz DR; Abel ED; Dayal S
Arterioscler Thromb Vasc Biol; 2023 Jan; 43(1):79-91. PubMed ID: 36325902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
